Use of data from registered clinical trials to identify gaps in health research and development

Bulletin of the World Health Organization

Volumn 91, Issue 6, 2013, Pages

  Viergever, Roderik F ^a   Terry, Robert F ^b   Karam, Ghassan ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DISABILITY; HEALTH CARE; HEALTH POLICY; POLICY DEVELOPMENT; PUBLIC HEALTH; RESEARCH AND DEVELOPMENT;

ARTICLE; CLINICAL TRIAL (TOPIC); COMMUNICABLE DISEASE; DATA ANALYSIS; DATA BASE; DISABILITY; HEALTH RESEARCH AND DEVELOPMENT; INJURY; MATERNAL DISEASE; MEDICAL RECORD; MEDICAL RESEARCH; NON COMMUNICABLE DISEASE; NUTRITIONAL DEFICIENCY; PERINATAL MORBIDITY; REGISTER; SOCIOECONOMICS;

CAUSE OF DEATH; CLINICAL TRIALS AS TOPIC; COST OF ILLNESS; DATABASES, FACTUAL; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; HUMANS; QUALITY-ADJUSTED LIFE YEARS; REGISTRIES; WORLD HEALTH ORGANIZATION;

EID: 84878451668     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.12.114454     Document Type: Article

References (53)

1. Commission on Health Research for Development. Health research: essential link to equity in development. New York: Oxford University Press; 1990.
2. The 10/90 report on health research 2003-2004. Geneva: Global Forum for Health Research; 2004.
3. Moon S, Bermudez J,'t Hoen E. Innovation and access to medicines for neglected populations: could a treaty address a broken pharmaceutical R&D system? PLoS Med 2012;9:e1001218. doi: http://dx.doi.org/10.1371/ journal.pmed.1001218 PMID:22615544
4. Chirac P, Torreele E. Global framework on essential health R&D. Lancet 2006;367:1560-1. doi: http://dx.doi.org/10.1016/S0140-6736(06)68672-8 PMID:16698397
5. Burke MA, Matlin SA, Monitoring financial flows for health research 2008: prioritizing research for health equity. Geneva: Global Forum for Health Research; 2008.
6. Moran M, Guzman J, Ropars A-L, McDonald A, Sturm T, Jameson N et al. Neglected disease research & development: how much are we really spending? Sydney: George Institute for International Health; 2009. Available from: http://www.policycures.org/downloads/G-FINDER_survey_of_global_R&D_funding_for_Neglected_diseases_2008.pdf [accessed 13 February 2013].
7. Viergever RF. Aid alignment for global health research: the role of HIROs. Health Res Policy Syst 2011;9:12. doi: http://dx.doi.org/10.1186/1478-4505-9-12 PMID:21414202
8. Terry RF, Allen L, Gardner CA, Guzman J, Moran M, Viergever RF. Mapping global health research investments, time for new thinking a Babel Fish for research data. Health Res Policy Syst 2012;10:28. doi: http://dx.doi. org/10.1186/1478-4505-10-28 PMID:22938160
9. De Angelis C, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Philadelphia: International Committee of Medical Journal Editors; 2004. Available from: http://www.icmje.org/clin_trial.pdf [accessed 31 August 2012].
10. Viergever RF, Ghersi D. The quality of registration of clinical trials. PLoS One 2011;6:e14701. doi: http://dx.doi.org/10.1371/journal.pone.0014701 PMID:21383991
11. Ghersi D, Pang T. En route to international clinical trial transparency. Lancet 2008;372:1531-2. doi: http://dx.doi.org/10.1016/S0140-6736(08)61635-9 PMID:18984176
12. Bian Z-X, Wu T-X. Legislation for trial registration and data transparency. Trials 2010;11:64. doi: http://dx.doi.org/10.1186/1745-6215-11-64 PMID:20504337
13. The registration of clinical trials. Dallas: World Association of Medical Editors; 2005. Available from: http://www.wame.org/resources/policies#trialreg [accessed 28 March 2013].
14. Drazen JM, Zarin DA. Salvation by registration. N Engl J Med 2007;356:184-5. doi: http://dx.doi.org/10.1056/NEJMe068291 PMID:17215537
15. Laine C, Horton R, DeAngelis CD, Drazen JM, Frizelle FA, Godlee F et al. Clinical trial registration: looking back and moving ahead. Lancet 2007;369:1909-11. doi: http://dx.doi.org/10.1016/S0140-6736(07)60894-0 PMID:17560431
16. Joint position on the disclosure of clinical trial information via clinical trial registries and databases. Geneva: International Federation of Pharmaceutical Manufacturers and Associations; 2009. Available from: http://clinicaltrials.ifpma.org/clinicaltrials/fileadmin/files/pdfs/EN/November_10_2009_Updated_Joint_Position_on_the_Disclosure_of_Clinical_Trial_Information_via_Clinical_Trial_Registries_and_Databases.pdf [accessed 28 March 2013].
17. o 39, de 05 de Junho de 2008. Brasilia: Agência Nacional de Vigilância Sanitária; 2008. Available from: [accessed 6 March 2013].http://www.fcm.unicamp.br/centros/cpc/index.php?option=com_docman&task=doc_download&gid=11&Itemid=165&ei=FdUaUZb2Oemf0QXr2YGwAQ&usg=AFQjCNE2XZf9UUm4cAO_6NCKryUq7ncyoQ&bvm=bv.42261806,d.d2k&cad=rja
18. World Health Organization [Internet]. International Clinical Trials Registry Platform (ICTRP): the WHO Registry Network. Geneva: WHO; 2012. Available from: http://www.who.int/ictrp/network/en/ [accessed 28 March 2013].
19. World Health Organization [Internet]. International Clinical Trials Registry Platform (ICTRP): unambiguous identification. Geneva: WHO; 2012. Available from: http://www.who.int/ictrp/unambiguous_identification/en/ [accessed 28 March 2013].
20. The global burden of disease: 2004 update. Geneva: World Health Organization; 2008.
21. The World Bank [Internet]. Country and lending groups. Washington: WB; 2012. Available from: http://data.worldbank.org/about/country-classifications/country-and-lending-groups [accessed 28 March 2013].
22. World Health Organization [Internet]. Definition of region groupings. Geneva: WHO; 2012. Available from: http://www.who.int/healthinfo/global_burden_disease/definition_regions/en/index.html [accessed 28 March 2013].
23. Wallis S. Binomial confidence intervals and contingency tests: mathematical fundamentals and the evaluation of alternative methods. London: University College London; 2012. Available from: http://www.ucl.ac.uk/english-usage/staff/sean/resources/binomialpoisson.pdf [accessed 28 March 2013].
24. World Health Organization [Internet]. Global burden of disease (GBD). Geneva: WHO; 2012. Available from: http://www.who.int/healthinfo/global_burden_disease/en/index.html [accessed 28 March 2013].
25. The World Bank [Internet]. The World Bank's comprehensive database of health, nutrition and population (HNP) statistics: population projections. Washington: WB; 2013. Available from: http://go.worldbank.org/H4UN4D5KI0 [accessed 28 March 2013].
26. Saving lives and creating impact: why investing in global health research 39. works. Sydney: Policy Cures; 2012. Available from: http://www.ghtcoalition.org/files/Savinglivesandcreatingimpact.pdf [accessed 28 March 2013].
27. Moran M, Guzman J, Ropars A-L, Jorgensen M, McDonald A, Potter S et al. The malaria product pipeline: planning for the future. Sydney: George Institute for International Health; 2008. 40.
28. Rohra DK. Representation of less-developed countries in pharmacology journals: an online survey of corresponding authors. BMC Med Res Methodol 2011;11:60. doi: http://dx.doi.org/10.1186/1471-2288-11-60 41. PMID:21545706
29. Califf RM, Zarin DA, Kramer JM, Sherman RE, Aberle LH, Tasneem A. 42. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010. JAMA 2012;307:1838-47. doi: http://dx.doi.org/10.1001/jama.2012.3424 PMID:22550198 43.
30. Glickman SW, McHutchison JG, Peterson ED, Cairns CB, Harrington RA, Califf RM et al. Ethical and scientific implications of the globalization of clinical 44. research. N Engl J Med 2009;360:816-23. doi: http://dx.doi.org/10.1056/ NEJMsb0803929 PMID:19228627
31. Viergever RF, Rademaker CMA, Ghersi D. Pharmacokinetic research in 45. children: an analysis of registered records of clinical trials. BMJ Open 2011;1:e000221. doi: http://dx.doi.org/10.1136/bmjopen-2011-000221 46. PMID:22021789
32. Culme-Seymour EJ, Davie NL, Brindley DA, Edwards-Parton S, Mason C. A decade of cell therapy clinical trials (2000-2010). Regen Med 2012;7:455-62. doi: http://dx.doi.org/10.2217/rme.12.45 PMID:22817619 47.
33. Nwaka S, Ilunga TB, Da Silva JS, Rial Verde E, Hackley D, De Vré R et al. Developing ANDI: a novel approach to health product R&D in Africa. PLoS Med 2010;7:e1000293. doi: http://dx.doi.org/10.1371/journal. pmed.1000293 PMID:20613865 48.
34. Bourgeois FT, Murthy S, Pinto C, Olson KL, Ioannidis JPA, Mandl KD. Pediatric versus adult drug trials for conditions with high pediatric disease burden. 49. Pediatrics 2012;130:285-92. doi: http://dx.doi.org/10.1542/peds.2012-0139 PMID:22826574
35. Wieseler B, Kerekes MF, Vervoelgyi V, McGauran N, Kaiser T. Impact of 50. document type on reporting quality of clinical drug trials: a comparison of registry reports, clinical study reports, and journal publications. BMJ 2012;344(jan03 1):d8141. doi: http://dx.doi.org/10.1136/bmj.d8141 51. PMID:22214759
36. Chan A-W. Out of sight but not out of mind: how to search for unpublished clinical trial evidence. BMJ 2012;344(jan03 2):d8013. doi: http://dx.doi. org/10.1136/bmj.d8013 PMID:22214892
37. World Health Organization. International Clinical Trials Registry Platform 52. (ICTRP).About registries. Geneva: WHO; 2012. Available from: http://www.who.int/ictrp/network/criteria_summary/en/index.html [accessed 28 March 2013]. 53.
38. Investing in health research and development. Report of the Ad Hoc Committee on Health Research Relating to Future Intervention Options. Geneva: World Health Organization; 1996. Available from http://apps.who.int/iris/handle/10665/63024?mode=simple&submit_simple=Show+simple+item+record [accessed 28 March 2013].
39. Research and development to meet health needs in developing countries: strengthening global financing and coordination. Report of the Consultative Expert Working Group on Research and Development: Financing and Coordination. Geneva: World Health Organization; 2012. Available from: http:// www.who.int/phi/cewg_report/en/index.html [accessed 28 March 2013].
40. Booth A, Clarke M, Dooley G, Ghersi D, Moher D, Petticrew M et al. The nuts and bolts of PROSPERO: an international prospective register of systematic reviews Syst Rev 2012;1:2.
41. Loder E, Groves T, Macauley D. Registration of observational studies. BMJ 2010;340:c950. doi: http://dx.doi.org/10.1136/bmj.c950 PMID:20167643
42. Williams RJ, Tse T, Harlan WR, Zarin DA. Registration of observational studies: is it time? CMAJ 2010;182:1638-42. doi: http://dx.doi.org/10.1136/bmj.c950 PMID:20167643
43. Lehman R, Loder E. Missing clinical trial data. BMJ 2012;344:d8158. doi: http://dx.doi.org/10.1136/bmj.d8158 PMID:22214760
44. Viergever RF, Olifson S, Ghaffar A, Terry RF. A checklist for health research priority setting: nine common themes of good practice. Health Res Policy Syst 2010;8:36. PMID:21159163
45. A bitter pill: the risks of carrying out clinical drug trials in developing countries. Amsterdam: Wemos Foundation; 2007.
46. Patrone D. Discrepancies between research advertisements and disclosure of study locations in trial registrations for USA-sponsored research in Russia. J Med Ethics 2010;36:431-4. doi: http://dx.doi.org/10.1136/jme.2010.035378 PMID:20605999
47. Reveiz L, Bonfill X, Glujovsky D, Pinzon CE, Asenjo-Lobos C, Cortes M et al. Trial registration in Latin America and the Caribbean's: study of randomized trials published in 2010. J Clin Epidemiol 2012;65:482-7. doi: http://dx.doi. org/10.1371/journal.pone.0033677 PMID:22438982
48. Dickersin K, Rennie D. Registering clinical trials. JAMA 2003;290:516-23. doi: http://dx.doi.org/10.1001/jama.290.4.516 PMID:12876095
49. Zarin DA, Tse T, Williams RJ, Califf RM, Ide NC. The ClinicalTrials.gov results database update and key issues. N Engl J Med 2011;364:852-60. doi: http://dx.doi.org/10.1056/NEJMsa1012065 PMID:21366476
50. Drazen JM. Transparency for clinical trials the TEST act. N Engl J Med 2012;367:863-4. doi: http://dx.doi.org/10.1056/NEJMe1209433 PMID:22873430
51. Reveiz L, Chan A-W, Krleza-Jerić K, Granados CE, Pinart M, Etxeandia I et al. Reporting of methodologic information on trial registries for quality assessment: a study of trial records retrieved from the WHO search portal. PLoS One 2010;5:e12484. doi: http://dx.doi.org/10.1371/journal. pone.0012484 PMID:20824212
52. Viergever RF, Ghersi D. Information on blinding in registered records of clinical trials. Trials 2012;13:210. doi: http://dx.doi.org/10.1186/1745-6215-13-210 PMID:23151201
53. Tasneem A, Aberle L, Ananth H, Chakraborty S, Chiswell K, McCourt BJ et al. The database for aggregate analysis of ClinicalTrials.gov (AACT) and subsequent regrouping by clinical specialty. PLoS One 2012;7:e33677. doi: http://dx.doi.org/10.1371/journal.pone.0033677 PMID:22438982